Pharmafile Logo

fight the fakes

- PMLiVE

AMR Action Fund raises $140m from new investors to tackle antimicrobial resistance

New investment adds to initial $1bn raised at the Fund's launch last year

- PMLiVE

IFPMA launches AMR Action Fund to tackle antimicrobial resistance

Pharma and health organisations unite to address public health threat

- PMLiVE

Global ban on pharma freebies, including cultural gifts

New rules cover mooncakes and bereavement payments

- PMLiVE

Greg Perry joins IFPMA as assistant director general

Will move to the global industry body from the Medicines Patent Pool

IFPMA names new communications director

Helen Gallagher joins the association from Ferring Pharmaceuticals

- PMLiVE

IFPMA appoints Fumie Griego as assistant director general

She joins the global pharma association from Merck KGaA

IFPMA appoints director general

Thomas Cueni brings expertise from Interpharma and EFPIA

IFPMA elects Pfizer’s Ian Read as president

Read succeeds Merck KGaA’s Dr Stefan Oschmann for a two-year term

- PMLiVE

Merck completes €15m Spanish biotech facility expansion

Enlarged Tres Cantos site will help meet demand for fertility and growth hormone drugs

- PMLiVE

The global scourge of counterfeit medicines

Pharmaceuticals are a prime target for organised crime

Merck KGaA’s Oschmann elected president of IFPMA

He takes over from Lilly’s John Lechleiter

- PMLiVE

IFPMA issues psoriasis call to action

Pharma industry body plans to raise awareness of disease

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links